Cargando…
Kaposi sarcoma in a patient treated with upadacitinib for rheumatoid arthritis
Autores principales: | Fournier, Cynthia, Sauder, Maxwell Benjamin, Kamil, Zaid Saeed, Butler, Marcus Otho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491778/ https://www.ncbi.nlm.nih.gov/pubmed/37693927 http://dx.doi.org/10.1016/j.jdcr.2023.07.019 |
Ejemplares similares
-
The use of interleukin-23 inhibitors to treat immune-related psoriasis induced by immune checkpoint inhibitors and in patients with active cancer: A case series and review of the literature
por: Fournier, Cynthia, et al.
Publicado: (2023) -
Dupilumab as a treatment for cutaneous immune-related adverse events induced by immune checkpoint inhibitors: A case series and review of the literature
por: Fournier, Cynthia, et al.
Publicado: (2023) -
Upadacitinib for rheumatoid arthritis
Publicado: (2020) -
Classic Kaposi Sarcoma: to treat or not to treat?
por: Vincenzi, Bruno, et al.
Publicado: (2015) -
Iatrogenic Kaposi's sarcoma following therapy for rheumatoid arthritis
por: Bergler-Czop, Beata, et al.
Publicado: (2016)